D. Lossignol

发表

Pain control in thoracic oncology

P. van Houtte, J. Sculier, Andrew P. White, 2017, European Respiratory Journal.

Psychological interventions to reduce pain in patients with cancer

D. Lossignol, 2013, Current opinion in oncology.

Systematic Overview of the Pharmacological Management of Postherpetic Neuralgia

L. Plaghki, B. Morlion, H. Adriaensen, 2004, Dermatology.

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER 2-Positive Breast Cancer

R. Greil, E. Winer, Minetta C. Liu, 2009 .

Is pain a universal norm

D. Lossignol, 2012 .

Supportive and palliative care: experience at the Institut Jules Bordet

J. Body, I. Mancini, D. Lossignol, 2002, Supportive Care in Cancer.

Opioid switch to oral methadone in cancer pain

J. Body, I. Mancini, D. Lossignol, 2000, Current opinion in oncology.

Supportive care for patients with gynaecological cancer

J. Klastersky, D. Lossignol, 2011 .

Supportive/palliative care in cancer patients: quo vadis?

J. Klastersky, D. Lossignol, M. Obiols, 2016, Supportive Care in Cancer.

[Euthanasia 2002-2014: The situation in Belgium].

D. Lossignol, 2016, Revue des maladies respiratoires.

Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.

P. Flamen, A. Awada, T. Gil, 2006, Anti-cancer drugs.

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

M. Piccart, J. Sculier, A. Awada, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cannabinoids: a new approach for pain control?

D. Lossignol, 2019, Current opinion in oncology.

Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature

C. Dumitrescu, D. Lossignol, 2013, Case reports in oncological medicine.

[Two years of legal practice of euthanasia in Belgium: comparison with the Netherlands. First evaluation in a palliative care unit].

M. Englert, D. Lossignol, B. Hanson, 2005, Revue medicale de Bruxelles.

6 Euthanasia , Dignity , Autonomy-A Reflection on Medicine

C. Dumitrescu, D. Lossignol, 2012 .

Euthanasia, Dignity, Autonomy - A Reflection on Medicine

C. Dumitrescu, D. Lossignol, 2011 .

End-of-life sedation: is there an alternative?

D. Lossignol, 2015, Current opinion in oncology.

[Euthanasia: status report in 2014].

D. Lossignol, 2014, Revue medicale de Bruxelles.

Euthanasia: from ethical debate to clinical reality

T. Berghmans, D. Lossignol, 2012, European Respiratory Journal.

Narrative ethics in the field of oncology

D. Lossignol, 2014, Current opinion in oncology.

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

R. Greil, E. Winer, Minetta C. Liu, 2009, Clinical Cancer Research.

Familial clustering of malignant astrocytomas

S. Piantadosi, C. Griffin, S. Grossman, 1990, Journal of Neuro-Oncology.

Successful use of ketamine for intractable cancer pain

J. Body, D. Lossignol, M. Obiols-Portis, 2005, Supportive Care in Cancer.

Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.

M. Fallon, R. Potts, Jeremy R Johnson, 2010, Journal of pain and symptom management.

Intravenous Methadone for Severe Cancer Pain: A Presentation of 10 Cases

D. Lossignol, I. Libert, B. Michel, 2012, ISRN Pain.

Pitfalls in the use of opiates in treatment of cancer pain

D. Lossignol, 1993, Supportive Care in Cancer.

A little help from steroids in oncology

D. Lossignol, 2016, Journal of translational internal medicine.

Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.

M. Piccart-Gebhart, P. Bedard, E. de Azambuja, 2010, Critical reviews in oncology/hematology.

EGF105084, a phase II study of lapatinib for brain metastases in patients (pts) with HER2+ breast cancer following trastuzumab (H) based systemic therapy and cranial radiotherapy (RT)

E. Winer, V. Diéras, C. Oliva, 2007 .

A phase I study of Taxotere (RP 56976 NSC 628503) administered as a one hour intravenous infusion on a weekly basis

M. Piccart-Gebhart, J. Sculier, E. Tomiak, 1991 .

The concept of rehabilitation of cancer patients.

J. Body, D. Lossignol, A. Ronson, 1997, Current opinion in oncology.

Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study.

K. Geboes, L. Duck, Vincent Vandenhaute, 2021, Clinical therapeutics.

An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.

M. Fallon, D. Lossignol, Mary Burnell-Nugent, 2013, Journal of pain and symptom management.

Breakthrough pain: progress in management

C. Dumitrescu, D. Lossignol, 2010, Current opinion in oncology.

Neuron Specific Enolase, a Biomarker of Breast Cancer Cerebral Metastasis

L. Ameye, C. Dumitrescu, D. Lossignol, 2017 .

Longitudinal Follow-up of TTS-Fentanyl Use in Patients with Cancer-Related Pain: Results of a Compassionate-Use Study with Special Focus on Elderly Patients

A. Mullie, D. Lossignol, J. Menten, 2002, Current medical research and opinion.

Validation of the Institut Curie simplified prognostic score for breast cancer meningeal carcinomatosis.

D. Larsimont, M. Piccart, F. Bidard, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Diagnosis and treatment of epidural metastases.

S. Grossman, D. Lossignol, 1990, Oncology.

[Pain and cancer].

D. Lossignol, 1991, Revue medicale de Bruxelles.

M. Fallon, D. Lossignol, Mary Burnell-Nugent, 2013, Journal of pain and symptom management.

Supportive/palliative care in cancer patients: quo vadis?

J. Klastersky, D. Lossignol, M. Obiols, 2016, Supportive Care in Cancer.